Cover Image

Editorial: Recent trends in anti-cancer drug discovery by in silico methods

Saved in:

Bibliographic Details
Main Authors:	Carmen Cerchia (Author), Jose Correa Basurto (Author), Angelo Lupo (Author), Antonio Lavecchia (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Deep generative models in the quest for anticancer drugs: ways forward
by: Virgilio Romanelli, et al.
Published: (2024)

Editorial: Insights in silico methods and artificial intelligence for drug discovery: 2022
by: José L. Medina-Franco
Published: (2023)

In Silico Methods for Drug Design and Discovery
Published: (2020)

Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
by: Moustafa S. Ghanem, et al.
Published: (2022)

Editorial: Computational chemogenomics: In silico tools in pharmacological research and drug discovery
by: Norberto Sánchez-Cruz, et al.
Published: (2023)

The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery
by: Hiroshi Komura, et al.
Published: (2023)

In Silico Models for Anti-COVID-19 Drug Discovery: A Systematic Review
by: Okello Harrison Onyango
Published: (2023)

Editorial: Advances in anti-malarial drug discovery
by: Agam Prasad Singh, et al.
Published: (2023)

In Silico Identification of Novel Inhibitors Targeting the Homodimeric Interface of Superoxide Dismutase from the Dental Pathogen <i>Streptococcus mutans</i>
by: Carmen Cerchia, et al.
Published: (2022)

Recent progress of ferroptosis in cancers and drug discovery
by: Xiang Wang, et al.
Published: (2024)

Recent Advances in Covalent Drug Discovery
by: Daniel Schaefer, et al.
Published: (2023)

Recent Fabrication Methods to Produce Polymer-Based Drug Delivery Matrices (Experimental and In Silico Approaches)
by: Anna Procopio, et al.
Published: (2022)

Editorial: Methods and application in experimental pharmacology and drug discovery: 2021
by: Letizia Polito, et al.
Published: (2022)

Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
by: Yazan J. Meqbil, et al.
Published: (2022)

Editorial: Natural compounds as scaffolds for the discovery of new anti-cancer drugs: Focus on terpenoids and flavonoids
by: Valeria P. Sülsen, et al.
Published: (2022)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
by: Alexandra Latini, et al.
Published: (2023)

Drug discovery in China: A snapshot of recent progress
by: Hongxi Hu, et al.
Published: (2022)

Recent advances in combinatorial biosynthesis for drug discovery
by: Sun H, et al.
Published: (2015)

Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery
by: Jinkyung Park, et al.
Published: (2021)

Editorial: Tumour microenvironment in cancer research and drug discovery
by: Nur Akmarina B. M. Said, et al.
Published: (2024)

Recent Advances in Anti-Tuberculosis Drug Discovery Based on Hydrazide-Hydrazone and Thiadiazole Derivatives Targeting InhA
by: Yoanna Teneva, et al.
Published: (2023)

Editorial: Reducing the Harm of Medication-Recent Trends in Pharmacovigilance
by: Elena Ramírez, et al.
Published: (2022)

Editorial: Recent trends in pharmacological treatment of musculoskeletal disorders
by: Zhixian Zong, et al.
Published: (2022)

In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19
by: Gema Lizbeth Ramírez Salinas, et al.
Published: (2023)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
by: Eric March-Vila, et al.
Published: (2017)

Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
by: Yurong Lai, et al.
Published: (2022)

Editorial: Recent trends and spotlight on nucleotide-based drugs: novel targets, their design, delivery, and clinical potential
by: Subhash Chander, et al.
Published: (2023)

Editorial: Artificial intelligence and machine learning for drug discovery, design and repurposing: methods and applications
by: Pan Zheng, et al.
Published: (2023)

'In silico' toxicology methods in drug safety assessment
by: Đukić-Ćosić Danijela, et al.
Published: (2021)

Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance
by: Ramalingam Peraman, et al.
Published: (2021)

Novel Reversible Inhibitors of Xanthine Oxidase Targeting the Active Site of the Enzyme
by: Rosario Rullo, et al.
Published: (2023)

Serotonin transporter: Recent progress of in silico ligand prediction methods and structural biology towards structure-guided in silico design of therapeutic agents
by: Kazuki Nagayasu
Published: (2022)

Recent Trends in Chronopharmaceutics, Pulsatile Drug Delivery System
by: Ahmed A. Albadri, et al.
Published: (2019)

Editorial: Reducing the harm of medication-recent trends in pharmacovigilance (volume II)
by: Elena Ramírez, et al.
Published: (2023)

Emerging drug design strategies in anti-influenza drug discovery
by: Chuanfeng Liu, et al.
Published: (2023)

Biophysical methods in early drug discovery
by: Geoffrey Holdgate, et al.
Published: (2019)

Discovery of novel anti-tumor compounds targeting PARP-1 with induction of autophagy through in silico and in vitro screening
by: Danfeng Shi, et al.
Published: (2022)

Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents
by: Ying-Hui Yuan, et al.
Published: (2023)

Molecular Insights into Coumarin Analogues as Antimicrobial Agents: Recent Developments in Drug Discovery
by: Rameshwar S. Cheke, et al.
Published: (2022)

Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
by: Katarina Vrbnjak, et al.
Published: (2024)